PARP7/HDACs-IN-1
PARP7/HDACs-IN-1 (compound 9l) is a dual-target inhibitor targeting PARP7/HDAC with anti-tumor activity. PARP7/HDACs-IN-1 inhibits different subtypes of PARPs and HDACs with IC50s of 83.3 nM (PARP1), 3.1 nM (PARP7), 35 nM (HDAC1), 30.3 nM (HDAC2), 35.4 nM (HDAC3), and 6.4 nM respectively. (HDAC6) [1]. br/[1].
Product Specifications
UNSPSC
12352005
Target
HDAC; PARP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/parp7-hdacs-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C1NN=CC(N[C@H](COCCC(N2CCN(CC2)C3=NC=C(C=N3)OCC4=CC=C(C=C4)/C=C/C(NO)=O)=O)C)=C1C(F)(F)F
Molecular Formula
C29H33F3N8O6
Molecular Weight
646.62
References & Citations
[1]Duan J L, et al. Design, Synthesis, and Structure–Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition[J]. Journal of Medicinal Chemistry, 2024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RDR-DSPP-Hu-01 96 Tests
Human Dentin Sialophosphoprotein (DSPP) ELISA Kit
Sign In for Pricing
View Details RDR-DSPP-Hu-02 48 Tests
Human Dentin Sialophosphoprotein (DSPP) ELISA Kit
Sign In for Pricing
View Details 
BNC742004-100 1x 100 µL
CD134, Mouse (OX40) (OX-86), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 